Skip to content

Clinical trials

Ventricular Remodeling trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ventricular Remodeling Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20053
20062
20072
20082
20092
20101
20111
20127
20142
20158
20163
20177
20188
20199
20207
20215
20229
20239
20243
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status31
Recruiting14
Terminated7
Active, not recruiting4
Not yet recruiting4
Suspended1
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioVentrix4
Chang Gung Memorial Hospital4
Assiut University3
University Hospital, Caen3
Ain Shams University2
Centro Cardiologico Monzino2
Federico II University2
Guangdong Provincial Hospital of Traditional Chinese Medicine2
Hospices Civils de Lyon2
Insel Gruppe AG, University Hospital Bern2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ventricular Remodeling104
Heart Failure29
Myocardial Infarction19
ST Elevation Myocardial Infarction14
Aortic Valve Stenosis5
Cardiomyopathy, Dilated5
Ventricular Dysfunction, Left5
Acute Coronary Syndrome4
Anterior Wall Myocardial Infarction4
Ventricular Dysfunction4

Trials

Showing 51 to 75 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.